Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NovaScan
AddedFeb 15, 2024
UpdatedJun 18, 2026
NovaScan

NovaScan

NovaScan, founded by a former Engineering Dean, provides instant, accurate cancer detection technology.

HQ
Milwaukee, WI, US
Founded
2003
Overview
Compare
Fundraising
Employees

NovaScan's mission is to revolutionize cancer detection with its breakthrough technology, offering solutions that require no capital equipment, are not size-constrained, and provide instantaneous, highly accurate results. Founded by a former Dean of the Engineering school at the University of Wisconsin Milwaukee, NovaScan aims to make cancer detection more accessible and efficient.

NovaScan has achieved significant milestones in the medical technology field, gaining recognition for its innovative approach to cancer detection. Its impact is marked by the potential to transform diagnostic procedures, reducing costs and improving patient outcomes.

NovaScan - Similar Companies

Scanit Technologies logo

Scanit Technologies

Oncodea logo

Oncodea

oncodea.com

Cellens logo

Cellens

cellensinc.com

NanoVision Diagnostics logo

NanoVision Diagnostics

Naveris logo

Naveris

naveris.com

Corscans logo

Corscans

Early Detection logo

Early Detection

cancer.us

Exact Sciences logo

Exact Sciences

exactsciences.com

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Smart Scan Medical Imaging logo

Smart Scan Medical Imaging

myssmi.com

Breath Diagnostics logo

Breath Diagnostics

Accunovo Biotechnologies logo

Accunovo Biotechnologies

GRAIL logo

GRAIL

grail.com

NanoCytomics logo

NanoCytomics

nano-cytomics.com

Arcscan logo

Arcscan

arcscan.com

NovaScan - Quick Facts

Who are NovaScan's competitors?

Companies similar to NovaScan include Scanit Technologies, Oncodea, Cellens and NanoVision Diagnostics.

When was NovaScan founded?

NovaScan was founded in 2003.

Where is NovaScan's headquarters located?

NovaScan's headquarters is located in Milwaukee, WI, US.

When was NovaScan's last funding round?

NovaScan's most recent funding round was for $3M (USD) in January 2021.

How much has NovaScan raised to-date?

As of Jan 22, 2021, NovaScan has raised a total of $7.5M (USD).

How many employees does NovaScan have?

NovaScan has 30 employees as of Feb 4, 2024.

NovaScan - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Detection
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research